These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 10652981)
41. Risks of oral contraceptive use in women over 35. Stenchever MA J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860 [TBL] [Abstract][Full Text] [Related]
42. Absence of correlation between oral contraceptive usage and cardiovascular mortality. Wiseman RA Int J Fertil; 1984; 29(4):198-208. PubMed ID: 6152441 [TBL] [Abstract][Full Text] [Related]
43. Oral contraceptives and venous thromboembolism. Paul C N Z Med J; 1996 Nov; 109(1033):413-5. PubMed ID: 8941290 [TBL] [Abstract][Full Text] [Related]
44. Combined oral contraceptive use among women with hypertension: a systematic review. Curtis KM; Mohllajee AP; Martins SL; Peterson HB Contraception; 2006 Feb; 73(2):179-88. PubMed ID: 16413848 [TBL] [Abstract][Full Text] [Related]
45. Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference? Lawrenson R; Farmer R Contraception; 2000 Aug; 62(2 Suppl):21S-28S; discussion 37S-38S. PubMed ID: 11102599 [TBL] [Abstract][Full Text] [Related]
46. Oral contraceptives and venous thromboembolism: an epidemiological review. Lidegaard O Eur J Contracept Reprod Health Care; 1996; 1(1):13-20. PubMed ID: 9678133 [TBL] [Abstract][Full Text] [Related]
48. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors. Tanis BC; Rosendaal FR Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494 [TBL] [Abstract][Full Text] [Related]
49. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet; 1995 Dec; 346(8990):1575-82. PubMed ID: 7500748 [TBL] [Abstract][Full Text] [Related]
51. The effects on mortality of the use of combined oral contraceptives. Oldfield K; Milne R; Vessey M Br J Fam Plann; 1998 Apr; 24(1):2-6. PubMed ID: 9719700 [TBL] [Abstract][Full Text] [Related]
52. Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare". Heinemann LA; Dinger JC; Assmann A; Minh TD Contraception; 2010 May; 81(5):401-7. PubMed ID: 20399946 [TBL] [Abstract][Full Text] [Related]
53. Health consequences of combined oral contraceptives. Hannaford P Br Med Bull; 2000; 56(3):749-60. PubMed ID: 11255559 [TBL] [Abstract][Full Text] [Related]
54. Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies. Shapiro S; Dinger J J Fam Plann Reprod Health Care; 2010 Jan; 36(1):33-8. PubMed ID: 20067670 [TBL] [Abstract][Full Text] [Related]
55. Contraceptives and cerebral thrombosis: a five-year national case-control study. Lidegaard Ø; Kreiner S Contraception; 2002 Mar; 65(3):197-205. PubMed ID: 11929641 [TBL] [Abstract][Full Text] [Related]
56. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women. Spitzer WO; Lewis MA; Heinemann LA; Thorogood M; MacRae KD BMJ; 1996 Jan; 312(7023):83-8. PubMed ID: 8555935 [TBL] [Abstract][Full Text] [Related]